A Meggio studies digestive disorders that can significantly affect people's quality of life. They have contributed to guidelines on functional dyspepsia, a common issue characterized by ongoing discomfort in the upper abdomen, and gastroesophageal reflux disease (GERD), where stomach acid frequently flows back into the esophagus, causing symptoms like heartburn. Their research emphasizes effective treatments and diagnostic strategies, such as the use of proton pump inhibitors (PPIs) for symptom relief. By collaborating with various medical societies, Meggio aims to sharpen medical practices surrounding these conditions and enhance patient management.
Key findings
In the guidelines for functional dyspepsia, it was recommended that patients over 45 should undergo endoscopy, according to key insights from five medical societies.
For GERD, a standard treatment using proton pump inhibitors (PPIs) for 4-8 weeks was recommended, which is considered an effective first-line therapy.
In research on complicated celiac disease, 37 out of 87 patients with complications died, with a striking 30 fatalities in patients who did not improve on a gluten-free diet immediately after diagnosis.
Frequently asked questions
Does Dr. Meggio study functional dyspepsia?
Yes, Dr. Meggio has developed guidelines for diagnosing and treating functional dyspepsia.
What treatments has Dr. Meggio researched for GERD?
Dr. Meggio recommends a 4-8 week course of proton pump inhibitors as an effective treatment for GERD.
Is Dr. Meggio's work relevant to patients with celiac disease?
Absolutely, Dr. Meggio's research helps patients with complicated celiac disease by identifying different patterns of disease progression and associated risks.
Publications in plain English
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG).
2025
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Savarino EV, Barberio B, Scarpignato C, Savarino V, Barbara G +21 more
Plain English This study examined how to best diagnose and treat gastroesophageal reflux disease (GERD) by gathering insights from five Italian medical societies. The experts agreed on 27 key recommendations, emphasizing a symptom-based approach for diagnosis and suggesting specific treatments, such as a standard 4-8 week course of proton pump inhibitors (PPIs) for most patients. These guidelines matter because they provide clear direction on managing GERD, helping to improve patient care and outcomes.
Who this helps: This helps doctors and patients with GERD.
Italian guidelines for the diagnosis and treatment of functional dyspepsia - joint consensus from the Italian societies of gastroenterology and endoscopy (SIGE), Neurogastroenterology and motility (SINGEM), hospital gastroenterologists and endoscopists (AIGO), digestive endoscopy (SIED) and general medicine (SIMG).
2025
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Sarnelli G, Pesce M, Barbara G, de Bortoli N, Sario AD +19 more
Plain English This research focused on creating guidelines for diagnosing and treating functional dyspepsia (FD), a common digestive disorder affecting many people. Experts from five Italian medical societies came together to agree on 24 key points about how to diagnose and manage FD, including the recommendation that patients over 45 should get an endoscopy to rule out other conditions. They found that a standard dose of proton pump inhibitors (PPIs) is effective as the first line of treatment, while other approaches, like dietary restrictions and certain medications, were not widely agreed upon.
Who this helps: These guidelines benefit doctors and healthcare providers who treat patients with functional dyspepsia.
Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients.
2019
Gut
Rugge M, Meggio A, Pravadelli C, Barbareschi M, Fassan M +5 more
Plain English This study looked at how the levels of gastritis (inflammation of the stomach lining) can predict the risk of developing stomach cancer. Out of 1,755 patients, 77.6% were at the lowest risk stage (stage 0), while 0.85% were at the highest risk stage (stage IV). It found that patients in the higher stages had a significant risk of developing stomach issues, with a rate of 63.1 cases of cancer per 1,000 people each year for those at stage IV.
Who this helps: This benefits patients with gastritis and doctors treating them, as it provides clear guidelines on cancer risk based on gastritis stages.
Priority and appropriateness of upper endoscopy out-patient referrals: Two-period comparison in an open-access unit.
2019
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Meggio A, Mariotti G, Gentilini M, de Pretis G
Plain English This study looked at the process of referring patients for upper endoscopy over two different years, 2006 and 2014, to see how well primary care doctors and specialists agreed on the urgency and appropriateness of these referrals. Researchers found that most patients were still considered low priority for these procedures (about 79% in 2006 and 75% in 2014) and that the agreement on referral urgency improved significantly from moderate to high. This is important because addressing the issue of low-priority referrals could help reduce unnecessary procedures and save healthcare costs.
Who this helps: This helps patients by minimizing unnecessary medical procedures and optimizing healthcare resources.
Chronic atrophic gastritis: Natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI].
2019
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Lahner E, Zagari RM, Zullo A, Di Sabatino A, Meggio A +4 more
Plain English This study focused on chronic atrophic gastritis (CAG), a condition often missed in diagnosis that affects many older adults and can lead to severe issues like gastric cancer. The research found that people with certain anemia or autoimmune disorders should be screened for CAG using reliable non-invasive tests, and that those with advanced CAG should have regular check-ups every 3 to 5 years to monitor their condition. Understanding and diagnosing CAG is crucial because it can lead to better treatment and management of patients at risk for gastric cancer.
Who this helps: This helps patients with chronic atrophic gastritis and their doctors.
Appropriateness and yield of surveillance colonoscopy in first-degree relatives of colorectal cancer patients: A 5-year follow-up population-based study.
2018
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Armelao F, Pertile R, Miori G, Franch R, Avancini I +9 more
Plain English This study looked at how effective colonoscopy screenings are for people who have a family history of colorectal cancer, specifically first-degree relatives of patients. Researchers followed 1,252 of these relatives and found that 93% participated in screenings compared to only 48% of individuals without such a family history. Although both groups showed similar rates of finding serious conditions during their screenings, it indicates that family members of colorectal cancer patients are more likely to get timely check-ups, which is crucial for early detection and treatment.
Who this helps: This helps patients with a family history of colorectal cancer and their doctors in planning effective screening.
A multicentre case control study on complicated coeliac disease: two different patterns of natural history, two different prognoses.
2014
BMC gastroenterology
Biagi F, Marchese A, Ferretti F, Ciccocioppo R, Schiepatti A +19 more
Plain English This study looked at two groups of patients with complicated celiac disease: those who do not improve with a gluten-free diet right after diagnosis (Type A) and those who initially improve but then relapse (Type B). They found that 37 out of 87 patients with complications died, with 30 deaths in Type A and 7 in Type B, indicating that Type A cases have a much higher mortality rate. This research highlights that patients with complicated celiac disease face serious health risks, and understanding the differences between these two patterns can better inform treatment and management.
Who this helps: This helps patients with celiac disease and their doctors in making more informed treatment decisions.
Errors and near misses in digestive endoscopy units.
2012
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Minoli G, Borsato P, Colombo E, Bortoli A, Casetti T +7 more
Plain English This study looked at mistakes and near misses in digestive endoscopy over two weeks in nine medical centers. They found a total of 232 reported events, with 230 of these being related to endoscopic procedures, which is about 10.3% of the total procedures conducted. Out of these incidents, 66 resulted in consequences for patients, while 164 were near misses that didn’t lead to harm; this shows that many potentially dangerous situations could be prevented.
Who this helps: This benefits both patients undergoing endoscopy and the medical staff responsible for their care.
Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA).
2012
Annals of surgery
Rugge M, Zaninotto G, Parente P, Zanatta L, Cavallin F +42 more
Plain English This study looked at patients with Barrett's esophagus (BE) in north-east Italy to understand how often the condition progresses to more severe problems like high-grade intraepithelial neoplasia (HG-IEN) or adenocarcinoma of the esophagus (BAc). Over a follow-up period of about 44 months involving 841 patients, only 22 progressed to these severe stages, which equates to a rate of 0.72 cases per 100 patient-years. The research found that certain factors, like visible abnormalities during endoscopy and the length of the BE, significantly increased the risk of progression, suggesting that careful monitoring is especially important for patients showing these signs.
Who this helps: This helps patients with Barrett's esophagus and their doctors by guiding monitoring and treatment decisions.
Plain English This study looked at screening colonoscopies in people who are closely related to patients with colorectal cancer, to see how often they have concerning growths (called neoplasia) compared to average-risk individuals. They found that 33.4% of these relatives had neoplasia, compared to 30.3% of people at average risk, with 11.3% of relatives having more serious growths known as advanced neoplasia compared to 6.3% of the average-risk group. Older age and being male increased the risk of advanced neoplasia, which highlights the importance of regular screenings for these higher-risk individuals.
Who this helps: This research benefits patients with a family history of colorectal cancer by emphasizing the need for earlier and more frequent screenings.
Improving the appropriateness of referrals and waiting times for endoscopic procedures.
2008
Journal of health services research & policy
Mariotti G, Meggio A, de Pretis G, Gentilini M
Plain English This study looked at how well general practitioners (GPs) and specialists agree on the urgency of patient referrals for important digestive procedures like gastroscopy and colonoscopy. Out of 438 patients, GPs classified 74.4% of referrals as low priority, often without a set waiting time. The findings showed that there was only a fair agreement between GPs and specialists on the urgency of referrals, and specialists found that about 22% of referrals were not appropriate. Improving communication between GPs and specialists could lead to faster and more accurate identification of patients who need urgent care.
Who this helps: This benefits patients who need timely access to diagnostic procedures.
The Veneto Region's Barrett's Oesophagus Registry: aims, methods, preliminary results.
2007
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Zaninotto G, Minnei F, Guirroli E, Ceolin M, Battaglia G +23 more
Plain English Researchers in the Veneto Region of Italy started a Barrett's Oesophagus Registry to gather important information about patients with this condition. Over 18 months, they enrolled 397 patients, finding that 75% had a Short Segment of Barrett's Oesophagus, while 25% had a Long Segment. The study showed that Long Segment patients are generally 5 years older and have a higher chance of neoplastic lesions—19% compared to 5% for Short Segment patients—highlighting the need for careful monitoring, especially for those suspected of having Long Segment Barrett's Oesophagus.
Who this helps: This research benefits patients diagnosed with Barrett's Oesophagus by improving diagnosis and monitoring strategies.
Gastritis staging in clinical practice: the OLGA staging system.
2007
Gut
Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L +2 more
Plain English Researchers studied a new system called OLGA to classify the severity of gastritis (stomach inflammation) and its link to stomach cancer risk. They looked at data from 439 patients and found that those with more advanced gastritis stages (III-IV) were significantly more likely to have cancerous lesions, while benign conditions were mostly found in the early stages (0-II). This matters because the OLGA system helps doctors better understand a patient's cancer risk and make more informed decisions about treatment.
Who this helps: This helps doctors and patients at risk of gastric cancer.